Bevacizumab in Extensive Small Cell Lung Cancer
Clinical trial NCT00930891 · COMPLETED
Trial details
- NCT number
- NCT00930891
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-07-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.